MHC rs116662199: Understanding This Genetic Variant
The rs116662199 variant is a single nucleotide polymorphism located within the Major Histocompatibility Complex (MHC) region of the human genome. Research has identified this specific genetic marker as being associated with idiopathic inflammatory myopathies, a group of rare autoimmune disorders.
What each genotype means
Typical inflammatory risk profile
You carry two copies of the common C allele at this locus within the major histocompatibility complex (MHC) region. Large-scale population studies show this baseline genotype is not associated with an increased susceptibility to autoimmune inflammatory myopathies relative to carriers of the minor risk allele. This result reflects population-level genetic patterns and does not guarantee the absence of autoimmune disease.
Carried by approximately 75% to 90% of individuals of European ancestry, and at even higher frequencies in East Asian populations.
Modestly increased susceptibility risk
You carry one copy of the ancestral minor T allele at this immune-associated genomic locus. Association research links this variant to a modest increase in relative risk for autoimmune conditions such as idiopathic inflammatory myopathies. However, because inflammatory myopathies are complex and rare conditions influenced by many genetic loci and environmental triggers, carrying this allele does not mean you will develop the condition.
Found in approximately 10% to 20% of individuals of European ancestry; it is observed at lower frequencies in non-European lineages.
Moderately increased susceptibility risk
You carry two copies of the ancestral minor T allele located in the MHC region. Genome-wide and immunogenetic research indicates that carrying two risk alleles is statistically correlated with a higher relative susceptibility to inflammatory myopathies compared to heterozygous or reference genotypes. Because these conditions are rare and multifactorial, this genotype alone is not diagnostic and most individuals with this profile never develop an inflammatory myopathy.
Observed in roughly 0.3% to 1.5% of people of European ancestry, and remains rare in most other global populations.
Understanding the MHC Region
The Major Histocompatibility Complex (MHC) is a dense cluster of genes located on chromosome 6 in humans. This region is critical for the immune system, as it encodes proteins that help the body distinguish between its own cells and foreign invaders like bacteria or viruses. Because of its vital role in immune function, the MHC is one of the most polymorphic and complex areas of the human genome. The variant rs116662199 sits within this highly variable landscape. Genetic variations in this region are frequently studied because they can influence how an individual's immune system responds to environmental triggers. When researchers identify a SNP like rs116662199 in this area, they are often looking at how subtle changes in DNA sequence might alter the presentation of antigens, potentially leading to an overactive or misdirected immune response that characterizes various autoimmune conditions.
The Role of MHC in Immune Function
The genes within the MHC region, often referred to as Human Leukocyte Antigen (HLA) genes in humans, are responsible for the production of cell-surface proteins. These proteins act like a display case, showing fragments of proteins from inside the cell to T-cells, which are the immune system's primary defenders. If the T-cells recognize these fragments as 'self,' they leave the cell alone. If they detect something foreign, they trigger an immune response. Because rs116662199 is located in this region, it is hypothesized that it may influence the structure or expression of these HLA proteins. While the exact functional mechanism of this specific SNP is still being investigated, its location suggests it could play a role in how effectively the immune system monitors cellular health. Understanding these mechanisms is a major focus of modern immunology, as it helps explain why some individuals are more susceptible to inflammatory diseases than others.
Research Associations and Evidence
The association between rs116662199 and idiopathic inflammatory myopathies has been highlighted in genome-wide association studies (GWAS). These studies scan the entire genome to find statistical links between specific genetic markers and health conditions. The evidence for this variant is considered moderate, meaning that while a statistical correlation has been observed, it does not imply a direct cause-and-effect relationship. Idiopathic inflammatory myopathies are complex, multifactorial conditions, meaning they are likely influenced by a combination of many genetic factors, environmental exposures, and lifestyle elements. The identification of this SNP provides a valuable piece of the puzzle for researchers, but it is not a diagnostic tool. It is important to note that having this variant does not mean an individual will develop a condition; rather, it indicates a potential difference in immune system regulation that warrants further scientific study to fully understand its clinical significance.
Interpreting Your Genetic Information
It is essential to approach genetic information with a clear understanding of what it can and cannot tell you. A genetic variant like rs116662199 is a data point, not a medical diagnosis. Because the association with inflammatory myopathies is based on population-level statistics, it cannot predict an individual's health outcome. If you have concerns about your health, symptoms of muscle weakness, or a family history of autoimmune disease, the most important step is to consult with a qualified healthcare professional or a genetic counselor. They can provide context based on your personal medical history, physical examinations, and other diagnostic tests. Never use genetic data to make decisions about your health or to self-diagnose. Genetic research is constantly evolving, and what we know today may be refined by future studies. Always rely on clinical expertise rather than raw genetic data when making decisions about your well-being.
How common is this variant?
The minor allele frequency for rs116662199 is approximately 0.05 to 0.12 in European lineages, indicating it is a relatively common variant in these populations.
Frequently asked questions
What is rs116662199?
rs116662199 is a specific genetic variant, or SNP, located in the MHC region of the human genome. It is a point in the DNA sequence where individuals may differ, and it has been studied for its potential link to inflammatory conditions.
Does having this variant mean I have an autoimmune disease?
No, having this variant does not mean you have or will develop an autoimmune disease. Genetic associations are based on statistical trends in large groups of people and cannot predict individual health outcomes.
Where can I learn more about my genetic results?
If you have received genetic testing results, the best resource is a genetic counselor or your primary care physician. They can help you interpret the information in the context of your personal and family medical history.
Is this variant common?
The variant is found at a minor allele frequency of approximately 5% to 12% in European populations. This makes it a relatively common variation within that specific ancestral group.
Sources & further reading
Educational information only, last refreshed 10/13/2026. Not medical advice — these associations describe population statistics, not individual predictions.
Curious what your genotype is for rs116662199?
Upload a raw DNA file from 23andMe, AncestryDNA, MyHeritage, or FamilyTreeDNA and see this variant — plus thousands more — interpreted in your full report.
Get my report — $29Related variants in MHC
This variant is associated with the MHC region, which recent GWAS have confirmed as a major genetic driver for idiopathic inflammatory myopathies.
This variant is located in the MHC region, which has been shown to contain multiple independent risk signals for idiopathic inflammatory myopathies.
This variant is located within the MHC Class 1 region, which has been confirmed by recent large-scale GWAS to harbor significant risk loci for idiopathic inflammatory myopathies.
This variant is associated with the MHC Class 1 region, which recent research confirms is a critical site for genetic risk in idiopathic inflammatory myopathies.